Company page
Poniard Pharmaceut
Poniard Pharmaceuticals, trading under the ticker PARD, is a public company based in America with a market capitalization of $149.9 million. The company focuses on developing innovative therapies for cancer treatment. Poniard is committed to advancing its pipeline and addressing unmet medical needs in oncology.
- Ticker
- PARD:OTC
- Asset type
- Stock
- Market cap
- $150
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD